Aravive Financial Statements From 2010 to 2024
| ARAVDelisted Stock | USD 1.49 0.21 12.35% |
Check Aravive financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aravive's main balance sheet or income statement drivers, such as , as well as many indicators such as . Aravive financial statements analysis is a perfect complement when working with Aravive Valuation or Volatility modules.
Aravive |
Aravive Company Shares Outstanding Analysis
Aravive's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Aravive Shares Outstanding | 73.56 M |
Most of Aravive's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aravive is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Aravive has 73.56 M of shares currently outstending. This is 59.25% lower than that of the Biotechnology sector and 31.16% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 87.14% higher than that of the company.
Aravive Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Aravive's current stock value. Our valuation model uses many indicators to compare Aravive value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aravive competition to find correlations between indicators driving Aravive's intrinsic value. More Info.Aravive is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Aravive by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Aravive Financial Statements
Aravive investors use historical fundamental indicators, such as Aravive's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Aravive. Please read more on our technical analysis and fundamental analysis pages.
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Aravive, Inc. was incorporated in 2008 and is headquartered in Houston, Texas. Aravive operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 23 people.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Aravive Stock
If you are still planning to invest in Aravive check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aravive's history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |